TITLE

Fidaxomicin for Clostridium difficile Infection

AUTHOR(S)
Safdar, Nasia; Craig, William A.
PUB. DATE
May 2011
SOURCE
New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1875
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Fidaxomicin Versus Vancomycin for Clostridium Difficile Infection," by T. J. Louie et al, in the February 3, 2011 issue.
ACCESSION #
60596269

 

Related Articles

  • Fidaxomicin for Clostridium difficile Infection. Linsky, Amy; Gupta, Kalpana; Hermos, John A. // New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1875 

    A letter to the editor is presented in response to the article "Fidaxomicin Versus Vancomycin for Clostridium Difficile Infection," by T. J. Louie et al, in the February 3, 2011 issue.

  • Fidaxomicin for Clostridium difficile Infection. Louie, Thomas J.; Gorbach, Sherwood; Sears, Pamela // New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1875 

    A response by T. J. Louie et al to letters to the editor about their article "Fidaxomicin Versus Vancomycin for Clostridium Difficile Infection" is presented.

  • Clostridium Difficile Disease and Vancomycin--Questionable Clinical Superiority. Tarchini, Giorgio // Clinical Infectious Diseases;7/15/2011, Vol. 53 Issue 2, p212 

    A letter to the editor is presented in response to an article related to the denial of coverage by health insurance companies in the U.S. for oral vancomycin therapy for clostridium difficile infection, in a previous issue of the periodical.

  • Comment on: Increasing Incidence of Community-Associated Atypical Clostridium Difficile Disease in Children. Pant, Chaitanya; Bass, Pat F. // Clinical Pediatrics;Sep2010, Vol. 49 Issue 9, p907 

    A letter to the editor is presented in response to an article on the frequency of community-acquired Clostridium difficile infection (CDI).

  • Letter to the Editor Response. Baker, Susan S.; Faden, Howard // Clinical Pediatrics;Sep2010, Vol. 49 Issue 9, p908 

    A response by Susan S. Baker and Howard Faden to a letter to the editor about their article on the frequency of community-acquired Clostridium difficile infection (CDI) is presented.

  • Decontamination of the Digestive Tract in ICU Patients. Gold, Howard; Peleg, Anton Y. // New England Journal of Medicine;5/14/2009, Vol. 360 Issue 20, p2138 

    The article presents a letter to the editor in response to the study "Decontamination of the Digestive Tract in ICU Patients" by De Smet and colleagues published in the January 1, 2009 issue.

  • Informing the public. Erban, Joseph // CMAJ: Canadian Medical Association Journal;8/17/2004, Vol. 171 Issue 4, p309 

    Presents a letter to the editor about the outbreak of Clostridium difficile infection.

  • Outbreak of Clostridium difficile Infection and Gatifloxacin Use in a Long-Term Care Facility. Mohr, John // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p875 

    Presents a letter to the editor about the outbreak of Clostridium difficile infection and Gatifloxacin use in a long-term care facility.

  • Outbreak of Clostridium difficile Infection and Gatifloxacin Use in a Long-Term Care Facility. Gaynes, Robert; Rimland, David; Killum, Edna; Lowery, H. Ken; Johnson, Ted; Kiligore, George; Tenover, Fred C. // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p876 

    Presents a letter to the editor about the outbreak of Clostridium difficile infection and Gatifloxacin use in a long-term care facility.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics